CD8A and neoplasm: Flow cytometric analysis of the tumor infiltrating lymphocytes showed that the addition of CDDP plus CBP501, but not CDDP, significantly upregulated the percentage of tumor infiltrating CD8+ T cells induced by anti-PD-1 treatment (Figure 5A, bottom panel).